Study compares the effectiveness of bivalent and monovalent booster vaccines against COVID-19 mortality in individuals aged 65 and older. It finds that bivalent boosters show higher vaccine effectiveness against COVID-19 mortality, particularly for the Omicron variant, compared to monovalent vaccines.
CureVac Announces Financial Results for the Second Quarter and First Half of 2023 and Provides Business Update – Biotech Investments
Issuer: CureVac / Key word(s): Quarter Results 17.08.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Financial